Top Markets
#1 Akedo Akedo +64.36%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.34%
#4 Cross Cross +45.41%
#5 Black Phoenix Black Phoenix +34.24%
#6 Velvet Velvet +30.05%
#7 OVERTAKE OVERTAKE +26.38%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.75%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.03%
#10 Palladium Network Palladium Network +12.84%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Aravive, Inc. Aravive, Inc.

Aravive, Inc.

ARAV
Classement en actions #38755
Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston,... Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston, Texas, dedicated to discovering and developing innovative treatments for life-threatening illnesses such as cancer and fibrosis. The company's primary therapeutic candidate, batiraxcept, is an ultrahigh-affinity decoy protein engineered to disrupt the GAS6-AXL signaling pathway. This drug is currently progressing through a Phase III clinical trial for platinum-resistant recurrent ovarian cancer, and is also being evaluated in Phase Ib/II studies for clear cell renal cell carcinoma and pancreatic adenocarcinoma. Aravive also has AVB-S6 in its pipeline, a soluble Fc-fusion protein aimed at blocking the activation of the same GAS6-AXL pathway. Beyond internal development, Aravive has forged strategic partnerships. This includes a collaboration with WuXi Biologics (Hong Kong) Limited to develop novel, high-affinity bispecific antibodies targeting cancer and fibrosis. Furthermore, a license agreement with 3D Medicines Inc. grants rights to develop and commercialize products featuring batiraxcept as the sole active ingredient for human oncological diseases across mainland China, Taiwan, Hong Kong, and Macau. Originally incorporated in 2008 as Versartis, Inc., the company adopted the name Aravive, Inc. in October 2018.
Prix de l'action
$0.0401
Dernière synchronisation: 2024-02-07
Capitalisation boursière
$818.60K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Aravive, Inc. (ARAV)

Catégorie

Healthcare
Le prix ARAV avec la capitalisation boursière de B
Aravive, Inc. Aravive, Inc.
ARAV
$0.0401
Capitalisation boursière de Aravive, Inc.(ARAV)
Capitalisation boursière: $818.60K
En August 2026, Aravive, Inc. a une capitalisation boursière de $818.60K. Cela fait de Aravive, Inc. la 38755th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Aravive, Inc. du 2014 au 2026
ARAV par rapport au top 5 des plus populaires stocks
Prix pour ARAV L’actif B La capitalisation boursière de B Résultats
Aravive, Inc. Aravive, Inc.
$266,675 $818.60K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.444T +665,025,860.98%
Aravive, Inc. Aravive, Inc.
$219,648 $818.60K
Apple Inc. Apple Inc.
AAPL
$4.484T +547,751,579.05%
Aravive, Inc. Aravive, Inc.
$204,100 $818.60K
Alphabet Inc. Alphabet Inc.
GOOG
$4.166T +508,977,533.05%
Aravive, Inc. Aravive, Inc.
$181,257 $818.60K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +452,013,382.11%
Aravive, Inc. Aravive, Inc.
$139,051 $818.60K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.839T +346,760,062.88%